home / stock / crtsf / crtsf news


CRTSF News and Press, Christian Hansen Hldg Ord From 01/23/23

Stock Information

Company Name: Christian Hansen Hldg Ord
Stock Symbol: CRTSF
Market: OTC

Menu

CRTSF CRTSF Quote CRTSF Short CRTSF News CRTSF Articles CRTSF Message Board
Get CRTSF Alerts

News, Short Squeeze, Breakout and More Instantly...

CRTSF - Novozymes: Wonderful Company, Almost Reasonable Price

Summary Novozymes is a Danish company that produces industrial enzymes, often used to replace chemicals in products and industrial processes. The company's products have a wide range of applications in household care, food and beverage, bio-energy, agriculture, feed, and even pharmaceut...

CRTSF - Seres Therapeutics: The Good And The Challenging

Seres' $100 million share placement with strategic partners, including Nestle, helps stabilize the share price. The C. difficile market - how big is it? Who can compete with the Seres/Nestle (Aimmune Therapeutics) global rollout for C. difficile recurrence? Seres has had two share...

CRTSF - Chr. Hansen: A Great Business, But Unfortunately Still Overvalued

Chr. Hansen is a great business and has a wide economic moat around its business. In the last few years, Chr. Hansen was rather struggling. Despite the share price dropping, it is still overvalued in my opinion. For further details see: Chr. Hansen: A Great Business, But...

CRTSF - Chr. Hansen Holding A/S (CHYHY) CEO Mauricio Graber on Q2 2022 Results - Earnings Call Transcript

Chr. Hansen Holding A/S (CHYHY) Q2 2022 Earnings Conference Call April 6 2022, 04:00 AM ET Company Participants Mauricio Graber - President and CEO Lise Mortensen - CFO Conference Call Participants Alexander Sloane - Barclays Christian Ryom - Nordea Markets Soren Samsoe - SEB Lars Topholm - C...

CRTSF - Chr. Hansen Holding A/S 2022 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Chr. Hansen Holding A/S in conjunction with their 2022 Q2 earnings call. For further details see: Chr. Hansen Holding A/S 2022 Q2 - Results - Earnings Call Presentation

CRTSF - Seres Therapeutics Is Playing A Long Game

Seres misses on earnings and revenue, although revenue was up 344% to $144.92 million. Net loss of $50.00 million in Q4 compared with $18.3 million in Q4 2020, due significantly to preparing for launch of SER-109. Key publication on SER-109 C.difficile results and signs remain goo...

CRTSF - Chr. Hansen Holding A/S 2021 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Chr. Hansen Holding A/S in conjunction with their 2021 Q4 earnings call. For further details see: Chr. Hansen Holding A/S 2021 Q4 - Results - Earnings Call Presentation

CRTSF - Chr. Hansen Holding A/S (CHYHY) CEO Mauricio Graber on Q4 2021 Results - Earnings Call Transcript

Chr. Hansen Holding A/S (CHYHY) Q4 2021 Earnings Conference Call October 14, 2021, 04:00 AM ET Company Participants Mauricio Graber - Chief Executive Officer Lise Skaarup Mortensen - Executive Vice President and CFO, Executive Board Member Conference Call Participants Soeren Samsoe - SEB Char...

CRTSF - Chr. Hansen Holding A/S (CHYHY) CEO Mauricio Graber on Q3 FY2021 Results - Earnings Call Transcript

Chr. Hansen Holding A/S (CHYHY) Q3 FY2021 Earnings Conference Call July 8, 2021 4:00 AM ET Company Participants Mauricio Graber - Chief Executive Officer Lise Skaarup Mortensen - Executive Vice President and CFO, Executive Board Member Conference Call Participants Lars Topholm - Carnegie Heid...

CRTSF - Chr. Hansen Holding A/S 2021 Q3 - Results - Earnings Call Presentation

The following slide deck was published by Chr. Hansen Holding A/S in conjunction with their 2021 Q3 earnings call. For further details see: Chr. Hansen Holding A/S 2021 Q3 - Results - Earnings Call Presentation

Previous 10 Next 10